AffiADA® Rituximab (Rituxan) Immunogenicity ELISA

Specifications

Technique
ADA

Description

Rituximab (Rituxan® ) is a chimeric mouse/human monoclonal antibody used for treating B cell malignancy, autoimmune conditions, and graft rejection by depleting B cells from the body. This immunogenicity assay employs the bridging ELISA technique.

Additional Attributes

Technique
ADA
Brand
AffiADA